Advertisement Fidelity
Home > Boards > US OTC > Medical - Drugs > Provectus Pharmaceuticals (PVCT)

new blog post

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
buccaneer1961 Member Profile
Member Level 
Followed By 274
Posts 41,026
Boards Moderated 20
Alias Born 02/24/10
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/18/2014 5:03:10 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 4/17/2014 5:15:30 PM
Provectus Biopharmaceuticals Signs Agreement with China’s Tririver Capital "Business Wire" - 4/14/2014 6:00:00 AM
Induction of Systemic Immunity Following Treatment of Tumors with PV-10 Reported by Moffitt Cancer Center Researchers at Amer... "Business Wire" - 4/7/2014 6:00:00 AM
Provectus Biopharmaceuticals’ PV-10 Data to Feature in Poster Presentation by Moffitt Cancer Center at the American Society... "Business Wire" - 4/2/2014 6:00:00 AM
Provectus Biopharmaceuticals’ PV-10 Data to Be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting "Business Wire" - 4/1/2014 6:30:00 AM
Provectus Biopharmaceuticals’ PV-10 Data to Be Presented at the HemOnc Today Melanoma and Cutaneous Malignancies Conference "Business Wire" - 4/1/2014 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/24/2014 5:17:57 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/24/2014 6:08:18 AM
Provectus Biopharmaceuticals Inc. Submits Application to FDA to Receive Breakthrough Therapy Designation for PV-10 for Treatm... "Business Wire" - 3/24/2014 6:05:00 AM
Securities Registration (investment Company Business Combination) (n-14/a) "Edgar (US Regulatory)" - 3/21/2014 5:05:06 PM
Definitive Materials Filed by Investment Companies. (497) "Edgar (US Regulatory)" - 3/21/2014 5:05:05 PM
Definitive Materials Filed by Investment Companies. (497) "Edgar (US Regulatory)" - 3/21/2014 5:03:53 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/21/2014 5:02:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/21/2014 5:01:11 PM
Provectus Appoints Dr. Joseph M. Chalil to Strategic Advisory Board "Business Wire" - 3/19/2014 6:05:00 AM
Mutual Fund Summary Prospectus (497k) "Edgar (US Regulatory)" - 3/13/2014 4:49:56 PM
Mutual Fund Summary Prospectus (497k) "Edgar (US Regulatory)" - 3/13/2014 4:49:07 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/13/2014 4:49:06 PM
Provectus Pharmaceuticals, Inc. Melanoma Version of PV-10 Completes Phase 2 and is Prepping for BTD "PR Newswire (US)" - 3/13/2014 12:04:00 PM
PV-10 Immune Mechanism Data to Be Presented at the American Association for Cancer Research Annual Meeting "Business Wire" - 3/6/2014 11:58:00 AM
Annual Report (management Company) (nsar-b) "Edgar (US Regulatory)" - 2/28/2014 12:23:32 PM
Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q) "Edgar (US Regulatory)" - 2/28/2014 12:23:30 PM
Mutual Fund Summary Prospectus (497k) "Edgar (US Regulatory)" - 2/28/2014 12:23:30 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist